NCT07416734 · NOT YET RECRUITING
RCT of HeartBot in Women
This trial is testing an AI chatbot app called HeartBot II to see whether it improves women's knowledge and awareness of heart attack symptoms. About 200 women will be randomly assigned to use the app now or wait 12 weeks before starting. It is a Phase NA study, meaning this is a behavioral and educational intervention being evaluated for effectiveness, not a drug or device requiring traditional phase classification.
You may qualify if
- Women
- 25 years or older
- Living in the US
- University of California, San Francisco Health patient
- Possessing a smartphone with a data plan or Wi-Fi access
You're excluded if
- Individuals who identify as male
- Having self-reported cognitive impairment
- Having history of heart disease or stroke
- Healthcare professional/trainee
- Working in the healthcare field
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-02-18